MTouche is currently in discussion with our manufacturing partner, Shanghai Fosun Long March Medical Science Co., Ltd. to collaborate and distribute Covid-19 mRNA-based vaccine when the product completed its phase 3 clinical trials and ready for mass vaccination and distribution. Shanghai Fosun Long March Medical Science Co., Ltd. is a wholly owned subsidiary of Shanghai Fosun Pharmaceutical Group, who has inked an agreement with BioNTech, the German partner, and Pfizer, the U.S. Pharma Group on the global development program, with the ultimate aim of securing global supply of a vaccine immediatelty upon regulatory approval. The Company will make necessary announcement when there is a material collaboration established,” Mr Tang concluded.
Formally signed the bilateral agreement on vaccine development and accessibility with Minister Wang Zhigang of China which will see Malaysia getting priority access for COVID-19 vaccines. This is part of the high-level bilateral committee under @HishammuddinH2O.
Pfizer says final data analysis shows Covid vaccine is 95% effective, plans to submit to FDA in days PUBLISHED WED, NOV 18 20206:46 AM ESTUPDATED 7 MIN AGO
Mtouch was also appointed by Shanghai Fosun Long March Medical Science Co Ltd (China) and Wuhan EasyDiagnosis Biomedicine Co Ltd. (China) as the authorised representative to promote, market and distribute Covid-19 RT-PCR detection and diagnostic kits and Covid-19 IgM/IgG rapid test kits in Malaysia.
Shanghai Fosun Long March Medical Science Co Ltd is a wholly owned subsidiary of Shanghai Fosun Pharmaceutical Group, who has inked an agreement with BioNTech, the German partner, and Pfizer, on the global development program, with the ultimate aim of securing global supply of a vaccine immediatelty upon regulatory approval. The company will make necessary announcement when there is a material collaboration established.
Probably they will appoint Mtouch to distribute vaccine too
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
InvestorJ
156 posts
Posted by InvestorJ > 2020-11-18 16:55 | Report Abuse
MTouche is currently in discussion with our manufacturing partner, Shanghai Fosun Long March Medical Science Co., Ltd. to collaborate and distribute Covid-19 mRNA-based vaccine when the product completed
its phase 3 clinical trials and ready for mass vaccination and distribution. Shanghai Fosun Long March Medical Science Co., Ltd. is a wholly owned subsidiary of Shanghai Fosun Pharmaceutical Group, who has inked an agreement with BioNTech, the German partner, and Pfizer, the U.S. Pharma Group on the global development program, with the ultimate aim of securing global supply of a vaccine immediatelty upon
regulatory approval. The Company will make necessary announcement when there is a material collaboration established,” Mr Tang concluded.
Formally signed the bilateral agreement on vaccine development and accessibility with Minister Wang Zhigang of China which will see Malaysia getting priority access for COVID-19 vaccines. This is part of the high-level bilateral committee under @HishammuddinH2O.
https://twitter.com/HishammuddinH2O/status/1328968127955296264?s=20
while waiting for the news , you already have approval from test kit news at here
https://www.thesundaily.my/business/mtouche-covid-19-test-kits-of-three-manufacturers-approved-by-health-ministry-s-medical-device-authority-NL5159395